Delay in funding.

The purpose of this study is to evaluate the effectiveness of Xperience, a no rinse antimicrobial solution, on joint infection rates in patients undergoing total hip (THA) and total knee (TKA) arthoplasty surgery.

Inclusion Criteria:

• Scheduled to undergo primary total hip (via direct anterior approach, press-fit components) or total knee arthroplasty (via manual approach, cemented components).
• Willing to comply with all study-related procedures and be available for the duration of the study.
• Provide signed and dated informed consent.

Exclusion Criteria:

• Unable to provide signed and dated informed consent.
• Unwilling or unable to comply with all study-related procedures.
• Known history of sensitivity or allergic reaction to any of the study products or its components, including any products used for standard of care (such as dressings or any coverings).
• Has underlying condition or state that, in the 'investigator's opinion, would make them too critically ill to complete the day 90 postoperative follow ups.
• Pregnant, planning to become pregnant, or nursing female subjects.
• Subject with any mental impairment or condition that would make them unable to properly consent without use of LAR or additional subject protections.
• Subject is a prisoner and/or part of a vulnerable subject population, which necessitates additional human research subject protections beyond the scope of this protocol.
• Subject with an active infection or systemic antibiotic therapy within 2 weeks prior to surgery with the exception of preoperative antimicrobial prophylaxis.